Manufacturing, Nucleic Acids

metabion Expands Oligonucleotide Production Capacity in Germany

July 14, 2023

German manufacturer metabion is conducting a multi-million euro expansion of its oligonucleotide manufacturing capacity in Munich East.

Synthego Launches New RNA Manufacturing Facility

May 16, 2023

Synthego has opened its new GMP-compliant RNA manufacturing facility in Redwood City, Calif., for CRISPR-enabled genomics therapeutics.

Ramping Up Nucleic Acid Therapy Development

May 03, 2023

The market potential of nucleic acid-based therapies have been pushed into the spotlight following the success of the COVID-19 vaccines.

Marrying RNA and Mass Spectrometry

April 05, 2023

Mass spectrometric techniques are providing insights in critical RNA-based therapeutic areas.

Agilent Gains Design Support from CRB for Manufacturing Facility Expansion

February 22, 2023

Agilent’s therapeutic nucleic acids facility gains architectural design support from CRB.

Preparing for a New Wave of mRNA Technologies

February 16, 2023

To prepare for emerging mRNA technologies, it is necessary to adapt fill/finish and cold chain capabilities.

Pfizer and Touchlight Enter Patent License Agreement for Use of dbDNA

July 13, 2022

Pfizer and Touchlight have signed a patent license agreement for Pfizer to use Touchlight’s doggybone DNA (dbDNA) in the manufacture of mRNA vaccines, therapeutics, and gene therapies.

Wacker Biotech Expands Germany Site with Construction of New mRNA Competence Center

July 12, 2022

Wacker is investing more than €100 million (US$100.5 million) to expand its Halle, Germany, site with an mRNA competence center.

Avantor and Cytovance Biologics Partner on Plasmid DNA Development

May 13, 2022

Through a collaboration, Avantor and Cytovance Biologics will accelerate plasmid optimization and sourcing services for viral vectors and mRNA-based vaccines and therapeutics.

Cytiva Provides Arranta Bio with Single-Use Manufacturing Platform for mRNA Products

February 01, 2022

Arranta Bio will use Cytiva’s FlexFactory single-use manufacturing platform to produce mRNA vaccines.